P. Walton

1.0k total citations
13 papers, 831 citations indexed

About

P. Walton is a scholar working on Genetics, Oncology and Cancer Research. According to data from OpenAlex, P. Walton has authored 13 papers receiving a total of 831 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 3 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in P. Walton's work include Estrogen and related hormone effects (9 papers), Effects and risks of endocrine disrupting chemicals (2 papers) and HER2/EGFR in Cancer Research (2 papers). P. Walton is often cited by papers focused on Estrogen and related hormone effects (9 papers), Effects and risks of endocrine disrupting chemicals (2 papers) and HER2/EGFR in Cancer Research (2 papers). P. Walton collaborates with scholars based in United Kingdom, Norway and United States. P. Walton's co-authors include Anthony Howell, D.J. DeFriend, J.F.R. Robertson, R.W. Blamey, Mitch Dowsett, Lars Ottestad, Per Eystein Lønning, Steinar Lundgren, Jürgen Geisler and Nicholas King and has published in prestigious journals such as The Lancet, British Journal of Cancer and Human Reproduction.

In The Last Decade

P. Walton

13 papers receiving 793 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Walton United Kingdom 7 696 363 229 219 132 13 831
D.J. DeFriend United Kingdom 7 631 0.9× 376 1.0× 187 0.8× 257 1.2× 150 1.1× 17 812
Susan M. Langan-Fahey United States 9 619 0.9× 258 0.7× 158 0.7× 281 1.3× 36 0.3× 12 862
Meei Huey Jeng United States 10 469 0.7× 241 0.7× 107 0.5× 258 1.2× 46 0.3× 12 647
Catherine Jones United States 9 414 0.6× 263 0.7× 203 0.9× 203 0.9× 95 0.7× 15 702
V C Jordan United States 9 394 0.6× 163 0.4× 90 0.4× 180 0.8× 30 0.2× 11 476
Y. Nishino Germany 18 517 0.7× 163 0.4× 64 0.3× 229 1.0× 97 0.7× 53 798
Edmund C. Chang United States 6 469 0.7× 218 0.6× 80 0.3× 378 1.7× 42 0.3× 6 716
V. Craig Jordan United States 9 392 0.6× 184 0.5× 121 0.5× 156 0.7× 19 0.1× 9 502
Alicia Parkes United Kingdom 5 464 0.7× 312 0.9× 145 0.6× 332 1.5× 39 0.3× 10 641
Cathleen D. Valentine United States 11 514 0.7× 175 0.5× 58 0.3× 499 2.3× 49 0.4× 12 775

Countries citing papers authored by P. Walton

Since Specialization
Citations

This map shows the geographic impact of P. Walton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Walton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Walton more than expected).

Fields of papers citing papers by P. Walton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Walton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Walton. The network helps show where P. Walton may publish in the future.

Co-authorship network of co-authors of P. Walton

This figure shows the co-authorship network connecting the top 25 collaborators of P. Walton. A scholar is included among the top collaborators of P. Walton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Walton. P. Walton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Walton, P., et al.. (2021). Tagraxofusp Treatment: Implications for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm. Clinical journal of oncology nursing. 25(2). E10–E16. 2 indexed citations
2.
Robertson, J.F.R., Anthony Howell, Daniel J. Friend, R.W. Blarney, & P. Walton. (1997). Duration of remission to ICI 182,780 compared to megestrol acetate in tamoxifen resistant breast cancer. The Breast. 6(4). 186–189. 26 indexed citations
3.
Howell, Anthony, D.J. DeFriend, RW Blamey, et al.. (1996). Pharmacokinetics, pharmacological and anti-tumour effects of the specific anti-oestrogen ICI 182780 in women with advanced breast cancer. British Journal of Cancer. 74(2). 300–308. 161 indexed citations
4.
Geisler, Jürgen, Nicholas King, Mitch Dowsett, et al.. (1996). Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer. British Journal of Cancer. 74(8). 1286–1291. 288 indexed citations
5.
Howell, Anthony, D.J. DeFriend, J.F.R. Robertson, et al.. (1996). Clinical studies with the specific ‘pure’ antioestrogen ICI 182780. The Breast. 5(3). 192–195. 2 indexed citations
6.
Howell, Anthony, D.J. DeFriend, R.W. Blamey, J.F.R. Robertson, & P. Walton. (1995). Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer. The Lancet. 345(8941). 29–30. 283 indexed citations
7.
8.
Thomas, Eric J., et al.. (1995). The Effects of ICI 182,780, a Pure Anti-Oestrogen, on the Hypothalamic-Pituitary-Gonadal Axis and on Endometrial Proliferation in Premenopausal Women. Obstetrical & Gynecological Survey. 50(6). 442–445. 2 indexed citations
9.
10.
DeFriend, D.J., Anthony Howell, J.F.R. Robertson, et al.. (1995). 86. Pharmacokinetics, systemic and antitumour effects of the specific antioestrogen ICI 182780 in women with advanced breast cancer. The Breast. 4(3). 251–252. 4 indexed citations
11.
12.
Nicholson, Robert I., Julia M.W. Gee, Colby L. Eaton, et al.. (1994). Pure antioestrogens in breast cancer - experimental and clinical observations. ORCA Online Research @Cardiff. 3 indexed citations
13.
Naylor, Hilary, et al.. (1987). P3 as an index of visual information processing.. PubMed. 40. 235–40. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D.J. DeFriend Breakdown of academic impact, for papers by Susan M. Langan-Fahey Breakdown of academic impact, for papers by Meei Huey Jeng Breakdown of academic impact, for papers by Catherine Jones Breakdown of academic impact, for papers by V C Jordan Breakdown of academic impact, for papers by Y. Nishino Breakdown of academic impact, for papers by Edmund C. Chang Breakdown of academic impact, for papers by V. Craig Jordan Breakdown of academic impact, for papers by Alicia Parkes Breakdown of academic impact, for papers by Cathleen D. Valentine
Rankless by CCL
2026